ABSTRACT

Introduction .................................................................................................................................486 Inorganic nanoparticles .........................................................................................................486 Magnetic nanoparticles .........................................................................................................486 Preparation of MNPs with multifunctional water-soluble polymers as capping ligands .................................................................................................................. 487 Properties of MNPs prepared with MWPs ......................................................................... 489

Controllability .................................................................................................................... 489 Stability ............................................................................................................................... 490 Easy modication .............................................................................................................. 490 Self-assembly of NPs ......................................................................................................... 491 Stimuli-responsive polymers for MNPs ......................................................................... 492 Biocompatibility ................................................................................................................. 494

Bioapplications of MNPs prepared with MWPs ............................................................... 495 Bioimaging.......................................................................................................................... 496 Magnetofection .................................................................................................................. 498 Magnetic hyperthermia .................................................................................................... 499 Magnetic separations ........................................................................................................502 Drug delivery .....................................................................................................................502